Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
Due to the rapid, vast, and emerging global spread of the Coronavirus Disease 2019 (COVID-19) pandemic, many drugs were quickly repurposed in a desperate attempt to unveil a miracle drug. Ivermectin (IVM), an antiparasitic macrocyclic lactone, was tested and confirmed for its in vitro antiviral acti...
Saved in:
Main Authors: | Hoda Awad (Author), Basmala Hassan (Author), Sara Dweek (Author), Yasmeen Aboelata (Author), Mutasem Rawas-Qalaji (Author), Iman Saad Ahmed (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. <i>Pharmaceuticals</i> 2022, <i>15</i>, 1068
by: Hoda Awad, et al.
Published: (2024) -
Formulation and optimization of ivermectin nanocrystals for enhanced topical delivery
by: Hoda Awad, et al.
Published: (2023) -
Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents
by: Tapas Kumar Mohapatra, et al.
Published: (2024) -
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
by: Lamia Al Ali, et al.
Published: (2022) -
Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use
by: Ousama Rachid, et al.
Published: (2018)